華明裝備(002270.SZ):特高壓直流產品正式投運
格隆匯11月28日丨華明裝備(002270.SZ)公佈,2022年11月27日國內首台採用公司全資子公司上海華明所生產分接開關的換流變壓器在“±500kV溪洛渡直流輸電工程”從西換流站正式投入運行。
華明SHZV Ⅱ-1300/72.5D-14271W換流變分接開關設計參數最大額定通過電流1300A,額定級電壓6000V,切換級容量6000kVA,並首次採用了國產真空滅弧室,電氣壽命30萬次,機械壽命150萬次。同時,也是首次採用公司主導研發具有油色譜監測等功能的國產有載分接開關在線監測系統,為產品運行保駕護航。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.